| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |